Printer Friendly

ABBOTT TO PURCHASE FOUR MILLION SHARES

 ABBOTT TO PURCHASE FOUR MILLION SHARES
 ABBOTT PARK, Ill., April 10 /PRNewswire/ -- The board of directors


of Abbott Laboratories (NYSE: ABT) today approved the purchase of up to 4 million shares of its common stock contingent upon the successful completion of the sale of Abbott's holding in Boston Scientific Corp. This authorization would be in addition to the six million share authorization announced in December 1991.
 Abbott announced previously that it had entered into a contract to sell its 20 percent holding in Boston Scientific Corp. to that corporation in conjunction with and, contingent upon, completion of Boston Scientific's contemplated initial public offering.
 Abbott Laboratories is a worldwide manufacturer of health care products employing some 46,000 people. In 1991, the company's sales and net earnings were $6.9 billion and $1.1 billion, respectively, with earnings per share of $2.55.
 -0- 4/10/92
 /CONTACT: Catherine Babington of Abbott Laboratories, 708-937-8943/
 (ABT) CO: Abbott Laboratories ST: Illinois IN: MTC SU:


TS -- NY043 -- 7247 04/10/92 13:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 10, 1992
Words:171
Previous Article:FIRST NATIONAL BANCORP REPORTS FIRST QUARTER 1992 RESULTS
Next Article:LAUREL SAVINGS ASSOCIATION ANNOUNCES NEW BOARD MEMBER


Related Articles
ABBOTT TO PURCHASE SIX MILLION SHARES; COMPANY DECLARES QUARTERLY DIVIDEND
ABBOTT CONFIRMS INTENT TO DIVEST STAKE IN BOSTON SCIENTIFIC
ABBOTT TO PURCHASE 20 MILLION SHARES OF ITS COMMON STOCK; COMPANY DECLARES QUARTERLY DIVIDEND
ABBOTT TO PURCHASE 20 MILLION SHARES; COMPANY DECLARES QUARTERLY DIVIDEND
Abbott Laboratories Announces 20 Million Share Buyback
Abbott Laboratories and Triangle Pharmaceuticals Announce $335 Million Worldwide Alliance to Market Six Antiviral Products.
Abbott Laboratories Furthers E-Commerce Strategy With Investment In ChemConnect.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters